发明授权
US08008298B2 Pyrrolopyrazine kinase inhibitors 有权
吡咯吡嗪激酶抑制剂

Pyrrolopyrazine kinase inhibitors
摘要:
The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables Q1, R, and X are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
公开/授权文献
信息查询
0/0